Community Engaged Research
Policy Support for New Alzheimer's Treatments: Regulation and Taxation
Project summary
Several new drugs for Alzheimer's prevention have shown efficacy in trials. In the US, such drugs received regulatory
approval and are also now insured by Medicare. Canada is currently lagging, with no regulatory approval for Alzheimer's
Researchers
Sweetman A; Longo C
Start date
October 1, 2024
End date
September 30, 2025